- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02714296
Evaluating the Effectiveness of Colon Preparation for Endoscopy Using Specialized Clinical Nutrition
April 11, 2017 updated by: Nutricia Advanced
Phase IV Prospective Sinle Center Randomised Three-arm Controlled Study Evaluating the Effectiveness of Colon Preparation for Endoscopy Using Specialized Clinical Nutrition
This study is an open, prospective, comparative diagnostic studies aimed at improving the colonoscopy results, by optimizing the way of preparation for endoscopy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Objective: to improve the quality of bowel preparation for endoscopy.
Research objectives:
- Compare the three methods of colon preparation for endoscopy
- To develop a rational strategy of preparing patients for endoscopy on the basis of the data obtained.
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Moscow, Russian Federation, 123103
- ГНЦ колопроктологии
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients older than 18 years with the recommendation to conduct a diagnostic colonoscopy
- Absence of contraindications to the use of specialized clinical nutrition products
Exclusion Criteria:
Conditions which are contraindicated for colonoscopy:
- The acute phase of cerebrovascular accident
- Acute myocardial infarction
- severe cardiovascular, pulmonary insufficiency and mixed
- Violations of the cardiac rhythm (paroxysmal bradyarrhythmia, atrial fibrillation with atrial fibrillation or paroxysmal atrial fibrillation, severe transverse heart block)
- Severe clinical forms (fulminant) inflammatory diseases of the colon (ulcerative colitis, Crohn's disease, ischemic colitis, radiation colitis, diverticulitis)
- Aortic aneurysm or heart
- Acute inflammatory infiltrates abdominal cavity (including diverticulitis)
- Suspicion of abscess of the abdominal cavity
- Peritonitis
- Hepatosplenomegaly
- Tense ascites
- hydrothorax, hydropericardium
- Severe blood coagulation
- Hemorrhagic vasculitis
- Pregnancy
- The patient's refusal to participate in the study
- Intolerance of specialized clinical nutrition products
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group Nutridrink 200ml
50 patients: two days before the investigation is assigned to a diet with the use of specialized clinical nutrition Nutridrink 200 ml 6 bottles per day as a sole source of nutrition.
On the day of the colonoscopy, as breakfast, allowed Nutridrink 1-2 bottles
|
Nutridrink 200 ml 6 bottles per day as a sole source of nutrition.
On the day of the colonoscopy, as breakfast, allowed Nutridrink 1-2 bottles
|
Active Comparator: Group Nutridrink compact protein
two days before the study is assigned diet with the addition of specialized clinical nutrition Nutridrinc compact protein 125 ml 2 bottles per day.
On the day of the colonoscopy, as breakfast, allowed Nutridrink compact protein 1-2 bottles
|
2 bottles per day.
On the day of the colonoscopy, as breakfast, allowed Nutridrink compact protein 1-2 bottles
|
No Intervention: Group control
only diet without receiving specialized nutrition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the degree of preparation in the colonoscopy (Chicago or Boston scale).
Time Frame: before colonoscopy
|
before colonoscopy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
tolerability
Time Frame: before colonoscopy
|
Visual analog scale assessment of tolerability of the preparation to the study
|
before colonoscopy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Elena Volkova
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2016
Primary Completion (Actual)
September 1, 2016
Study Completion (Actual)
November 1, 2016
Study Registration Dates
First Submitted
March 16, 2016
First Submitted That Met QC Criteria
March 16, 2016
First Posted (Estimate)
March 21, 2016
Study Record Updates
Last Update Posted (Actual)
April 13, 2017
Last Update Submitted That Met QC Criteria
April 11, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Nutricia-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonoscopy
-
Borland-Groover ClinicValley Medical Products, LLC is paying for the study and is the sponsor....CompletedColonoscopy | Screening Colonoscopy | Surveillance ColonoscopyUnited States
-
Josue AliagaCompleted
-
Endostart srlCompleted
-
Hospital Central Norte PEMEXCompletedPerformance of Colonoscopy | Tolerance of ColonoscopyMexico
-
VA Office of Research and DevelopmentVA Palo Alto Health Care System; VA Northern California Health Care SystemCompletedWater Exchange Colonoscopy | Unsedated Colonoscopy | Cap | Colonoscopy PainUnited States
-
Rambam Health Care CampusUnknownInadequate Preparation for Colonoscopy; Personalized Colonoscopy PreparationIsrael
-
Dalin Tzu Chi General HospitalCompletedColonoscopy | Intubation Time | Cap-assisted ColonoscopyTaiwan
-
Valduce HospitalCompletedUnsedated Colonoscopy | Warm Water | CO2 ColonoscopyItaly
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...UnknownColonoscopy | Complete Colonoscopy | Cecum Intubation Time | İleum Intubation TimeTurkey
-
Daewoong Pharmaceutical Co. LTD.Not yet recruiting
Clinical Trials on Nutridrink 200 ml
-
Enrollme.ru, LLCDanone NutriciaCompleted
-
Nutricia ResearchCompletedColorectal Cancer | Lung CancerNorway, Netherlands, Belgium, Lithuania, Estonia, Poland, Portugal
-
Ankara Etlik City HospitalNot yet recruitingAnxiety | Post Operative Pain | Nausea and Vomiting, PostoperativeTurkey
-
Shaheed Zulfiqar Ali Bhutto Medical UniversityCompletedCytokine Release Syndrome | Covid-19 PneumoniaPakistan
-
National Heart and Lung InstituteNutricia Research FundationCompletedChronic Heart Failure | Cardiac CachexiaPoland, Germany
-
Radoslaw Pach, MD, Ph DCompletedElderly Infection | Nutrition Disorders in Old Age | Nutritional Supplement Toxicity
-
Enrollme.ru, LLCDanone NutriciaCompletedLung CancerRussian Federation
-
Lawson Health Research InstituteCompletedPostoperative Air LeakCanada
-
GE HealthcareQuintiles, Inc.; Physician Reference LaboratoryCompleted
-
Nutricia ResearchCompletedOncology | Taste, AlteredNetherlands